Elderly patients > 65 years of age with acute myeloid leukemia and normal karyotype benefit from intensive therapeutic programs.
Am J Hematol
; 91(6): E302-3, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-26928240
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Karyotype
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2016
Document type:
Article
Affiliation country: